A simple echocardiographic estimate of right ventricular-arterial coupling to assess severity and outcome in pulmonary hypertension on chronic lung diseaseTo the Editor:The adaptation of right ventricular (RV) systolic function to afterload is a major determinant of outcome in pulmonary hypertension [1]. The gold standard measurement of RV-pulmonary arterial (PA) coupling is the ratio of end-systolic to arterial elastances (E es /E a ) which is optimal for RV flow output at minimal energy cost at values between 1.5 and 2 [2]. Progressive RV-PA uncoupling is associated with maintained RV dimensions down to E es /E a values of around 0.8 [3]. Thus, the evaluation of RV-PA coupling would theoretically allow monitoring of the transition from compensated to decompensated RV function in pulmonary hypertension. However, measuring RV-PA coupling at the bedside is technically demanding and invasive. Therefore, simpler imaging surrogates are being evaluated. One of those is the ratio of tricuspid annular plane systolic excursion (TAPSE) as a surrogate of contractility and systolic pulmonary artery pressure (PASP) as a surrogate of afterload, both measured using echocardiography (M-mode for TAPSE and Doppler assessment of the maximum velocity of tricuspid regurgitation for PASP) [4]. The TAPSE/PASP ratio has emerged as a potent predictor of outcome in heart failure [5] as well as in pulmonary arterial hypertension (PAH) [6].Pulmonary hypertension secondary to chronic lung diseases (PH-LD) is most often mild to moderate, with many patients having a mean pulmonary artery pressure (PAP) <35 mmHg. A small percentage of patients referred for evaluation in dedicated centres may have severe pulmonary hypertension with mean PAP in the range reported in PAH [7]. However, RV function is often altered even in mild-to-moderate PH-LD, and is an important determinant of survival and functional status in PH-LD [7,8]. We therefore explored the functional significance and prognostic relevance of the TAPSE/PASP ratio in PH-LD.We analysed patients with PH-LD and idiopathic PAH (iPAH) enrolled in the prospectively recruiting Giessen PH Registry [9]. The diagnosis of PH-LD was established by a multidisciplinary board before enrolment in the Giessen PH registry [9] between December 2004 and March 2012. Follow-up data were retrieved from the Giessen PH Registry up to February 2018. The analysis included consecutive patients with complete echocardiographic (day 1) and invasive haemodynamic data (day 2) and complete follow-up. The patients with iPAH (n=193) were a subset of a previously reported cohort of 290 patients with PAH [6]. The investigation was approved by the ethics committee of the Faculty of Medicine at the University of Giessen (Approval No. 186/16, 266/11). All participating patients gave written informed consent.As recently updated [7], PH-LD was defined by a mean PAP of ⩾21 mmHg (21-24 mmHg with pulmonary vascular resistance (PVR) ⩾3 Wood Units, or ⩾25 mmHg alone), with mean PAP ⩾35 mmHg alone or mean PAP ⩾25 mmHg with low cardiac ...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.